Drug Report History #280426
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v2-FR | Version v2-FR |
|---|---|---|
| Language | French | French |
| Date Updated | 2026-03-12 | 2026-03-12 |
| Drug Identification Number | 02520508 | 02520508 |
| Brand name | TEVA-SITAGLIPTIN MALATE / METFORMIN | TEVA-SITAGLIPTIN MALATE / METFORMIN |
| Common or Proper name | SITAGLIPTIN MALATE/METFORMIN 50/850MG TABLETS | SITAGLIPTIN MALATE/METFORMIN 50/850MG TABLETS |
| Company Name | TEVA CANADA LIMITED | TEVA CANADA LIMITED |
| Ingredients | METFORMIN HYDROCHLORIDE SITAGLIPTIN | METFORMIN HYDROCHLORIDE SITAGLIPTIN |
| Strength(s) | 850MG 50MG | 850MG 50MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 500 | 500 |
| Anatomical Therapeutical Chemical (ATC) code | A10BD | A10BD |
| Anatomical Therapeutical Chemical (ATC) description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2026-03-10 | 2026-03-10 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Item is on Suspended Supply until further notice | Item is on Suspended Supply until further notice |
| Health Canada comments |